Crystal Crop Protection’s ₹455.49 crore initial public offering (IPO) entered its second day of bidding today, November 19, 2026, with a price band of ₹259 to ₹272 per share. As of 10:05 AM on Day 2, the issue had been subscribed 1.48 times.
The IPO will remain open for subscription until November 20, 2026. The allotment is expected to be finalised on November 23, 2026, while the company’s shares are scheduled to list on the BSE and NSE on November 26, 2026.
The expected IPO schedule is as follows:
|
Event |
Date |
|
Subscription Opening Date |
18 November 2026 |
|
Subscription Closing Date |
20 November 2026 |
|
Basis of Allotment Date |
23 November 2026 |
|
Refund Initiation Date |
25 November 2026 |
|
Credit of Shares |
25 November 2026 |
|
Listing on BSE and NSE |
26 November 2026 |
Note: The allotment and listing dates are tentative and may be revised.
Explore other Upcoming IPOs on BSE and NSE.
[November 19, 2026, 10:05 A.M.]
|
Category |
Subscription (x) |
|
Qualified Institutional Buyers (QIBs) |
2.07x |
|
Non-Institutional Investors (NIIs) |
0.87x |
|
Retail Individual Investors (RIIs) |
1.39x |
|
Total |
1.48x |
The company intends to utilise the net proceeds from the fresh issue towards:
Founded in 1994, Crystal Crop Protection Limited provides a wide range of agricultural solutions, primarily focusing on agrochemicals and seeds. Its product portfolio covers herbicides, fungicides, insecticides, biostimulants, bioprotectants, plant growth regulators, liquid fertilisers, micronutrients, and seeds for field crops, vegetables and flowers.
The company operates an integrated business model that covers research and development, seed breeding, technology-driven manufacturing and distribution across India.
|
Particulars |
For the three-month period ended June 30, 2026 (in ₹ crore) |
FY26 (in ₹ crore) |
FY25 (in ₹ crore) |
|
Revenue from operations |
1,197.14 |
3,151.97 |
2,690.51
|
|
EBITDA |
241.78 |
456.23 |
315.28 |
|
Profit After Tax (PAT) |
135.78 |
144.91 |
118.39 |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here